Panagiota Litsa

[ 1 ] - Access to Care for Multiple Sclerosis in Times of Economic Crisis in Greece – the HOPE II Study

Background While there is currently no cure for multiple sclerosis (MS), treatment with biologic diseasemodifying drugs (bDMDs) can reduce the impact of the condition on the lives of patients. In Greece, the regulatory change in the distribution system of bDMDs, limited their administration through the designated pharmacies of the National Organization for Healthcare Services Provision (EOPYY) ...